loadpatents
name:-0.087069034576416
name:-0.055710077285767
name:-0.0062580108642578
Gonda; Igor Patent Filings

Gonda; Igor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gonda; Igor.The latest application filed is for "liposomal anti-infective formulations to inhibit non-tuberculous mycobacteria (ntm) microaggregate formation and establishment of ntm biofilm".

Company Profile
5.53.72
  • Gonda; Igor - San Francisco CA
  • Gonda; Igor - South Yarra AU
  • Gonda; Igor - Hayward CA US
  • Gonda; Igor - Melbourne AU
  • Gonda; Igor - Victoria AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 11,116,765 - Gonda , et al. September 14, 2
2021-09-14
Liposomal Anti-infective Formulations To Inhibit Non-tuberculous Mycobacteria (ntm) Microaggregate Formation And Establishment Of Ntm Biofilm
App 20210007985 - GONDA; Igor ;   et al.
2021-01-14
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20200323845 - Gonda; Igor ;   et al.
2020-10-15
pH-Modulated Formulations for Pulmonary Delivery
App 20200297722 - Cipolla; David C. ;   et al.
2020-09-24
Antibiotic Formulations For Treating Of Cavity Infections
App 20200253960 - Kind Code
2020-08-13
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20190328731 - GONDA; Igor ;   et al.
2019-10-31
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 10,376,508 - Gonda , et al. A
2019-08-13
Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
Grant 9,987,227 - Cipolla , et al. June 5, 2
2018-06-05
Liposomal formulations that form drug nanocrystals after freeze-thaw
Grant 9,968,555 - Cipolla , et al. May 15, 2
2018-05-15
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20180092912 - GONDA; Igor ;   et al.
2018-04-05
Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
Grant 9,857,387 - Gonda , et al. January 2, 2
2018-01-02
Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
Grant 9,844,548 - Gonda , et al. December 19, 2
2017-12-19
Diagnosis And Treatment Methods For Entry Of Gastrointestinal Contents Into Respiratory Tract
App 20170184620 - Gonda; Igor ;   et al.
2017-06-29
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20170071934 - GONDA; Igor ;   et al.
2017-03-16
Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
Grant 9,592,220 - Gonda March 14, 2
2017-03-14
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 9,532,986 - Gonda , et al. January 3, 2
2017-01-03
pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
App 20160331744 - CIPOLLA; David C. ;   et al.
2016-11-17
Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
Grant 9,457,006 - Gonda , et al. October 4, 2
2016-10-04
Method And Composition For Transdermal Drug Delivery
App 20160250227 - DIPIETRO; Tony ;   et al.
2016-09-01
Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
Grant 9,421,185 - Gonda , et al. August 23, 2
2016-08-23
Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
Grant 9,372,198 - Gonda June 21, 2
2016-06-21
Nanocrystals Formed In A Microenvironment
App 20160120806 - CIPOLLA; David C. ;   et al.
2016-05-05
Method and composition for transdermal drug delivery
Grant 9,180,194 - Dipietro , et al. November 10, 2
2015-11-10
Novel Liposomal Formulations That Form Drug Nanocrystals After Freeze-thaw
App 20150283076 - CIPOLLA; David C. ;   et al.
2015-10-08
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20150283133 - GONDA; Igor ;   et al.
2015-10-08
Diagnosis Of Entry Of Gastrointestinal Contents Into Respiratory Tract Of Humans And Animals
App 20150168432 - GONDA; Igor ;   et al.
2015-06-18
Inhaled Surfactant-modified Liposomal Formulations Providing Both An Immediate And Sustained Release Profile
App 20150110855 - CIPOLLA; David C. ;   et al.
2015-04-23
Method and composition for transdermal drug delivery
Grant 8,993,520 - Dipietro , et al. March 31, 2
2015-03-31
Method And Composition For Transdermal Drug Delivery
App 20150087623 - DIPIETRO; Tony ;   et al.
2015-03-26
Methods For Inhalation Of Smoke-free Nicotine
App 20140261474 - GONDA; IGOR
2014-09-18
Diagnosis And Treatment Methods For Entry Of Gastrointestinal Contents Into Respiratory Tract
App 20140194502 - Gonda; Igor
2014-07-10
Diagnosis And Treatment Methods For Entry Of Gastrointestinal Contents Into Respiratory Tract
App 20140194503 - Gonda; Igor ;   et al.
2014-07-10
Diagnosis And Treatment Methods For Entry Of Gastrointestinal Contents Into Respiratory Tract
App 20140194504 - Gonda; Igor ;   et al.
2014-07-10
Systems and methods for effecting cessation of tobacco use
Grant 8,689,803 - Gonda April 8, 2
2014-04-08
Method and composition for transdermal drug delivery
Grant 8,435,944 - Dipietro , et al. May 7, 2
2013-05-07
Systems and methods for effecting cessation of tobacco use
Grant 8,381,739 - Gonda February 26, 2
2013-02-26
Systems and Methods for Effecting Cessation of Tobacco Use
App 20120305011 - GONDA; Igor
2012-12-06
Systems and methods for effecting cessation of tobacco use
Grant 8,256,433 - Gonda September 4, 2
2012-09-04
Deep Lung Pulmonary Delivery Of Treprostinil
App 20120177693 - Cipolla; David C. ;   et al.
2012-07-12
Diagnosis Of Entry Of Gastrointestinal Contents Into Respiratory Tract Of Humans And Animals
App 20110312017 - GONDA; Igor
2011-12-22
Systems And Methods Used In Conjunction With Nicotine Vaccines For Effecting Cessation Of Tobacco Use
App 20110182831 - GONDA; IGOR
2011-07-28
Method And Composition For Transdermal Drug Delivery
App 20100322884 - DiPietro; Tony ;   et al.
2010-12-23
Ph-modulated Formulations For Pulmonary Delivery
App 20100209538 - Cipolla; David C. ;   et al.
2010-08-19
Method Of Treating Diabetes Mellitus In A Patient
App 20090241950 - Gonda; Igor ;   et al.
2009-10-01
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 7,490,603 - Gonda , et al. February 17, 2
2009-02-17
Dual Release Nicotine Formulations, And Systems And Methods For Their Use
App 20090004249 - Gonda; Igor
2009-01-01
Systems And Methods For Effecting Cessation Of Tobacco Use
App 20090005423 - Gonda; Igor
2009-01-01
Dual Release Nicotine Formulations, And Systems And Methods For Their Use
App 20090004250 - Gonda; Igor
2009-01-01
Method of treating diabetes mellitus in a patient
Grant 7,448,375 - Gonda , et al. November 11, 2
2008-11-11
Method of Treating Diabetes Mellitus in a Patient
App 20080264416 - Gonda; Igor ;   et al.
2008-10-30
Method and System for Rapid Transdermal Administration
App 20080226699 - Finnin; Barrie Charles ;   et al.
2008-09-18
Systems And Methods For Effecting Cessation Of Tobacco Use
App 20080138423 - GONDA; Igor
2008-06-12
Dual Release Nicotine Formulations, And Systems And Methods For Their Use
App 20080138399 - Gonda; Igor
2008-06-12
Dual Release Nicotine Formulations, And Systems And Methods For Their Use
App 20080138398 - Gonda; Igor
2008-06-12
Systems And Methods For Effecting Cessation Of Tobacco Use
App 20080138294 - GONDA; Igor
2008-06-12
Method Of Use Of Monomeric Insulin As A Means For Improving The Reproducibility Of Inhaled Insulin
App 20080099010 - Gonda; Igor ;   et al.
2008-05-01
Inhaled Insulin Dosage Control Delivery Enhanced By Controlling Total Inhaled Volume
App 20080099011 - Gonda; Igor ;   et al.
2008-05-01
Method of Use of Monomeric Insulin as a Means for Improving the Reproducibility of Inhaled Insulin
App 20080102129 - Gonda; Igor ;   et al.
2008-05-01
Method Of Treating Diabetes Mellitus In A Patient
App 20080060644 - Gonda; Igor ;   et al.
2008-03-13
Method and Composition for Treatment of Cutaneous Lesions
App 20080027033 - Gonda; Igor ;   et al.
2008-01-31
Method of Treatment for Undesired Effect Following Transdermal or Topical Drug Delivery
App 20070255197 - Humberstone; Andrew Jonathan ;   et al.
2007-11-01
Method for treating diabetes mellitus in a patient
Grant 7,278,419 - Gonda , et al. October 9, 2
2007-10-09
Methods of delivering aerosolized polynucleotides to the respiratory tract
Grant 7,244,714 - Gonda , et al. July 17, 2
2007-07-17
Method and composition for transdermal drug delivery
App 20060280783 - Dipietro; Tony ;   et al.
2006-12-14
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
App 20060124125 - Gonda; Igor ;   et al.
2006-06-15
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
App 20060093556 - Gonda; Igor ;   et al.
2006-05-04
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
Grant 7,028,686 - Gonda , et al. April 18, 2
2006-04-18
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 7,021,309 - Gonda , et al. April 4, 2
2006-04-04
DNase liquid solutions
Grant 7,018,825 - Chan , et al. March 28, 2
2006-03-28
Method of treating diabetes mellitus in a patient
App 20050274377 - Gonda, Igor ;   et al.
2005-12-15
Transdermal aerosol compositions
App 20050186141 - Gonda, Igor ;   et al.
2005-08-25
Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
App 20050019926 - Gonda, Igor ;   et al.
2005-01-27
Method of treatment of a female suffering from androgen insufficiency
App 20050002868 - Gonda, Igor ;   et al.
2005-01-06
Method for treating diabetes mellitus in a patient
App 20040182383 - Gonda, Igor ;   et al.
2004-09-23
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
App 20040089290 - Gonda, Igor ;   et al.
2004-05-13
Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols
App 20040062717 - Rosell, Joan ;   et al.
2004-04-01
Method of use of monomeric insulin as a means for improving the reproducibilty of inhaled insulin
App 20040062722 - Gonda, Igor ;   et al.
2004-04-01
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
Grant 6,688,304 - Gonda , et al. February 10, 2
2004-02-10
Insulin delivery enhanced by coached breathing
Grant 6,647,987 - Gonda , et al. November 18, 2
2003-11-18
Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
App 20030096774 - Gonda, Igor ;   et al.
2003-05-22
Aerosol-forming porous membrane with certain pore structure
Grant 6,543,442 - Gonda , et al. April 8, 2
2003-04-08
DNase Liquid solutions
App 20030054532 - Chan, Hak-Kim ;   et al.
2003-03-20
Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols
App 20030017121 - Rosell, Joan ;   et al.
2003-01-23
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
App 20030000519 - Gonda, Igor ;   et al.
2003-01-02
Optimization of the molecular properties and formulation of proteins delivered by inhalation
App 20020168323 - Gonda, Igor
2002-11-14
Insulin delivery enhanced by coached breathing
App 20020157677 - Gonda, Igor ;   et al.
2002-10-31
Aerosol generation using sterile multiple dose containers
App 20020134373 - Gonda, Igor
2002-09-26
Method of treating diabetes mellitus in a patient
App 20020124852 - Gonda, Igor ;   et al.
2002-09-12
Use of electrolytes (lons in solution) to suppress charging of inhalation aerosols
App 20020127186 - Rosell, Joan ;   et al.
2002-09-12
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 6,431,167 - Gonda , et al. August 13, 2
2002-08-13
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 6,431,166 - Gonda , et al. August 13, 2
2002-08-13
Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols
App 20020106331 - Rosell, Joan ;   et al.
2002-08-08
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 6,427,681 - Gonda , et al. August 6, 2
2002-08-06
Insulin delivery enhanced by coached breathing
Grant 6,408,854 - Gonda , et al. June 25, 2
2002-06-25
Formulation and devices for monitoring the efficacy of the delivery of aerosols
App 20020073991 - Gonda, Igor
2002-06-20
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
App 20020059932 - Gonda, Igor ;   et al.
2002-05-23
Minimizing thermally induced aggregation of DNase in solution with calcium
Grant 6,383,788 - Chan , et al. May 7, 2
2002-05-07
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
App 20020046750 - Gonda, Igor ;   et al.
2002-04-25
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
App 20020035992 - Gonda, Igor ;   et al.
2002-03-28
Formulation and devices for monitoring the efficacy of the delivery of aerosols
Grant 6,349,719 - Gonda February 26, 2
2002-02-26
Cationic liposomes
App 20020012998 - Gonda, Igor ;   et al.
2002-01-31
Method of treating diabetes mellitus in a patient
App 20010045213 - Gonda, Igor ;   et al.
2001-11-29
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
App 20010037805 - Gonda, Igor ;   et al.
2001-11-08
Aerosol-forming porous membrane with certain pore structure
App 20010010224 - Gonda, Igor ;   et al.
2001-08-02
Formulation and devices for monitoring the efficacy of the delivery of aerosols
App 20010010223 - Gonda, Igor
2001-08-02
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 6,250,298 - Gonda , et al. June 26, 2
2001-06-26
Method and device for creating aerosol with porous membrane with certain pore structure
Grant 6,230,706 - Gonda , et al. May 15, 2
2001-05-15
Coarse spray delivery of functional biologic material
Grant 6,227,195 - Gonda May 8, 2
2001-05-08
Formulation and devices for monitoring the efficacy of the delivery of aerosols
Grant 6,192,882 - Gonda February 27, 2
2001-02-27
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
Grant 6,167,880 - Gonda , et al. January 2, 2
2001-01-02
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
Grant 6,131,567 - Gonda , et al. October 17, 2
2000-10-17
Aerosol-forming porous membrane with certain pore structure
Grant 6,070,575 - Gonda , et al. June 6, 2
2000-06-06
Method of treating a diabetic patient by aerosolized administration of insulin lispro
Grant 6,024,090 - Gonda , et al. February 15, 2
2000-02-15
Method of delivering insulin lispro
Grant 5,970,973 - Gonda , et al. October 26, 1
1999-10-26
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
Grant 5,941,240 - Gonda , et al. August 24, 1
1999-08-24
Device and method for directing aerosolized mist to a specific area of the respiratory tract
Grant 5,906,202 - Schuster , et al. May 25, 1
1999-05-25
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
Grant 5,888,477 - Gonda , et al. March 30, 1
1999-03-30
Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
Grant 5,884,620 - Gonda , et al. March 23, 1
1999-03-23
Method of maintaining a diabetic patient's blood glucose level in a desired range
Grant 5,873,358 - Gonda , et al. February 23, 1
1999-02-23
Insulin delivery enhanced by coached breathing
Grant 5,743,250 - Gonda , et al. April 28, 1
1998-04-28
Company Registrations
SEC0001247692GONDA IGOR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed